1,087
Views
12
CrossRef citations to date
0
Altmetric
Research Papers

Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children

, , , , , , , & show all
Pages 358-376 | Received 30 Jul 2014, Accepted 22 Sep 2014, Published online: 31 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Eun-Ju Ko & Sang-Moo Kang. (2018) Immunology and efficacy of MF59-adjuvanted vaccines. Human Vaccines & Immunotherapeutics 14:12, pages 3041-3045.
Read now
Claudia Maria Trombetta, Elena Gianchecchi & Emanuele Montomoli. (2018) Influenza vaccines: Evaluation of the safety profile. Human Vaccines & Immunotherapeutics 14:3, pages 657-670.
Read now
Claudia Maria Trombetta & Emanuele Montomoli. (2016) Influenza immunology evaluation and correlates of protection: a focus on vaccines. Expert Review of Vaccines 15:8, pages 967-976.
Read now

Articles from other publishers (9)

Kulbir Kaur, Meenakshi Sachdeva, Monika Rana, Anil Chauhan, Ragini Bhatia, Pranita Pradhan, Shivani Saini & Meenu Singh. (2023) Efficacy of cell culture-derived influenza vaccines for children: A systematic review and meta-analysis. Journal of Pediatric Pulmonology 2:2, pages 43.
Crossref
Charlotte Switzer, Chris P. Verschoor, Eleanor Pullenayegum, Pardeep Singh & Mark Loeb. (2022) Adjuvant-attenuated symptom severity of influenza infections in vaccinated children. Infectious Medicine 1:3, pages 163-170.
Crossref
Eve Versage, Esther van Twuijver, Wim Jansen, Ad Theeuwes, Daphne Sawlwin & Matthew Hohenboken. (2021) Analyses of Safety Profile and Homologous Antibody Responses to a Mammalian Cell-Based, MF59-Adjuvanted, A/H5N1, Pandemic Influenza Vaccine across Four Phase II/III Clinical Trials in Healthy Children, Adults, and Older Adults. Vaccines 9:12, pages 1468.
Crossref
Yu-Ju Lin, Chiao-Ni Wen, Ying-Ying Lin, Wen-Chi Hsieh, Chia-Chen Chang, Yi-Hsuan Chen, Chian-Hui Hsu, Yun-Jui Shih, Chang-Hsun Chen & Chi-Tai Fang. (2020) Oil-in-water emulsion adjuvants for pediatric influenza vaccines: a systematic review and meta-analysis. Nature Communications 11:1.
Crossref
Michael I. Hauser, David J. Muscatello, Annabel C.Y. Soh, Dominic E. Dwyer & Robin M. Turner. (2019) An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines. Vaccine 37:31, pages 4246-4255.
Crossref
Sharon E Frey, Sepehr Shakib, Pornthep Chanthavanich, Peter Richmond, Timothy Smith, Terapong Tantawichien, Claudia Kittel, Peter Jaehnig, Zenaida Mojares, Bikash Verma, Niranjan Kanesa-thasan & Matthew Hohenboken. (2019) Safety and Immunogenicity of MF59-Adjuvanted Cell Culture–Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly. Open Forum Infectious Diseases 6:4.
Crossref
Amanda L. Wilkins, Dmitri Kazmin, Giorgio Napolitani, Elizabeth A. Clutterbuck, Bali Pulendran, Claire-Anne Siegrist & Andrew J. Pollard. (2017) AS03- and MF59-Adjuvanted Influenza Vaccines in Children. Frontiers in Immunology 8.
Crossref
Alex C. D. Salyer, Giuseppe Caruso, Karishma K. Khetani, Lauren M. Fox, Subbalakshmi S. Malladi & Sunil A. David. (2016) Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen. PLOS ONE 11:2, pages e0149848.
Crossref
K.M. Damer & C.M. Jung. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 307 334 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.